Market Place
Sourcing Support
Shandong New Time’s Generics Brivaracetam Receives Approval in US
26 Feb 2026 //
FDA
Zydus’ Generics Ivermectin Receives Approval in US
26 Feb 2026 //
FDA
Ajanta Pharma’s Generics Empagliflozin Receives Approval in US
25 Feb 2026 //
FDA
Rubin Research’s Generics Cetirizine HCl Receives Approval in US
25 Feb 2026 //
FDA
App’s Generics Hydrocortisone Receives Approval in US
25 Feb 2026 //
FDA
Dr Reddy’s Generics Dexmedetomidine HCl Receives Approval in US
25 Feb 2026 //
FDA
Eton Pharma’s Desmoda Receives Approval in US
25 Feb 2026 //
FDA
Eugia Pharma’s Generics Everolimus Receives Approval in US
25 Feb 2026 //
FDA
Natco’s Generics Alectinib Receives Approval in US
25 Feb 2026 //
FDA
Cipla’s Generics Palbociclib Receives Approval in US
25 Feb 2026 //
FDA
Amneal Ireland’s Generics Macitentan Receives Approval in US
25 Feb 2026 //
FDA
App Pharma’s Generics Sodium Sulfate Receives Approval in US
24 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Sitagliptin Receives Approval in US
24 Feb 2026 //
FDA
AQ USA Inc’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
MedisourceRx’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
Yichang Humanwell’s Generics Micafungin Receives Approval in US
24 Feb 2026 //
FDA
Orbicular’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Biocon Pharma’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Ajanta’s Generics Sitagliptin Phosphate Receives Approval in US
24 Feb 2026 //
FDA
Fourrts’ Generics Pregabalin Receives Approval in US
24 Feb 2026 //
FDA
Immedica Pharma’s Biologics Loargys Receives Approval in US
23 Feb 2026 //
FDA
Caplin’s Generics Sodium Phosphates Receives Approval in US
23 Feb 2026 //
FDA
Centaur Pharms’ Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Indoco’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Lupin’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Alkem’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Zhejiang Poly`s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Hainan Poly’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Armstrong’ Generics Ipratropium Bromide Receives Approval in US
23 Feb 2026 //
FDA
Alkem’s Generics Sitagliptin Phosphate Receives Approval in US
23 Feb 2026 //
FDA
Micro’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Apotex’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Alembic’s Generics Efinaconazole Receives Approval in US
23 Feb 2026 //
FDA
Vanda Pharms’ Bysanti Receives Approval in US
20 Feb 2026 //
FDA
Avyxa’s Favlyxa Receives Approval in US
20 Feb 2026 //
FDA
Invagen Pharms’ Generics Rivaroxaban Receives Approval in US
20 Feb 2026 //
FDA
Teva Pharms’ Generics Linagliptin Receives Approval in US
20 Feb 2026 //
FDA
Breckenridge Pharms’ Generics Tofacitinib Receives Approval in US
19 Feb 2026 //
FDA
Avet Lifes’ Generics Doxycycline Hyclate Receives Approval in US
19 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Aripiprazole Receives Approval in US
18 Feb 2026 //
FDA
Padagis Pharma’s Generics Midazolam Receives Approval in US
18 Feb 2026 //
FDA
MSN Pharma’s Generics Afatinib Receives Approval in US
18 Feb 2026 //
FDA
Cosmetic Manufacturers Pty’s Receives FDA Warning Letter
17 Feb 2026 //
FDA
Navinta’s Generics Sodium Phenylbutyrate Receives Approval in US
17 Feb 2026 //
FDA
Nat’s Generics Idelalisib Receives Approval in US
17 Feb 2026 //
FDA
Zydus’ Generics Bosentan Receives Approval in US
17 Feb 2026 //
FDA
Natco Pharma’s Generics Idelalisib Receives Approval in US
17 Feb 2026 //
FDA
Zydus Pharms’ Generics Bosentan Receives Approval in US
17 Feb 2026 //
FDA
Micro’s Generics Colchicine Receives Approval in US
17 Feb 2026 //
FDA
Janssen’s Biologics Rybrevant Fasproi Receives Approval in US
13 Feb 2026 //
FDA
Zydus’ Generics Metronidazole Receives Approval in US
13 Feb 2026 //
FDA
Janssen’s Biologics Rybrevant Faspro Receives Approval in US
13 Feb 2026 //
FDA
Avyxa’s Avopef Receives Approval in US
13 Feb 2026 //
FDA
Zydus’s Generics Metronidazole Receives Approval in US
13 Feb 2026 //
FDA
Macleods Pharms’ Generics Colchicine Receives Approval in US
13 Feb 2026 //
FDA
West-Ward Pharms’s Generics Tapentadol Receives Approval in US
13 Feb 2026 //
FDA
Zydus’ Generics Ammonium Lactate Receives Approval in US
12 Feb 2026 //
FDA
Zydus’s Generics Ammonium Lactate Receives Approval in US
12 Feb 2026 //
FDA
Macleods Pharms’ Generics Milnacipran HCl Receives Approval in US
12 Feb 2026 //
FDA
Acrotech Biopharma’s Adquey Receives Approval in US
12 Feb 2026 //
FDA
